Search by Drug Name or NDC
NDC 50090-4632-00 Ondansetron 8 mg/1 Details
Ondansetron 8 mg/1
Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is ONDANSETRON.
MedlinePlus Drug Summary
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 50090-4632-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ondansetron
Product Information
| NDC | 50090-4632 |
|---|---|
| Product ID | 50090-4632_ef67ba26-cfad-4a52-81b2-c2ae62512b34 |
| Associated GPIs | 50250065007240 |
| GCN Sequence Number | 041563 |
| GCN Sequence Number Description | ondansetron TAB RAPDIS 8 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 20046 |
| HICL Sequence Number | 019058 |
| HICL Sequence Number Description | ONDANSETRON |
| Brand/Generic | Generic |
| Proprietary Name | Ondansetron |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ondansetron |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | ONDANSETRON |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090469 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4632-00 (50090463200)
| NDC Package Code | 50090-4632-0 |
|---|---|
| Billing NDC | 50090463200 |
| Package | 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50090-4632-0) |
| Marketing Start Date | 2019-10-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |